This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Eastman Chemical's Q2 Earnings and Revenues Miss, Down Y/Y
by Zacks Equity Research
EMN's Q2 earnings and sales miss estimates as weak demand, tariffs, and soft end markets weigh on its performance.
Eastman Chemical (EMN) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Eastman Chemical (EMN) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Eastman Chemical (EMN) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of -6.98% and -0.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate LyondellBasell (LYB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
LyondellBasell (LYB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Eastman Chemical (EMN) Q2 Earnings Expected to Decline
by Zacks Equity Research
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EMN Debuts Biodegradable Micropowder Esmeri CC1N10 for Color Cosmetics
by Zacks Equity Research
Eastman debuts Esmeri CC1N10, a biodegradable micropowder that boosts cosmetic performance while meeting EU microplastic rules.
Albemarle (ALB) Down 3.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
DOW Stock Down 22% in 3 Months: Should You Buy the Dip?
by Anindya Barman
While DOW benefits from investment in high-return projects and cost actions, weak end-market demand and declining estimates cast a pall on its prospects.
Eastman Chemical's Earnings Surpass Estimates, Sales Miss in Q1
by Zacks Equity Research
The sales volume mix of EMN is mainly impacted by customer inventory destocking in acetate tow products in Q1.
Here's What Key Metrics Tell Us About Eastman Chemical (EMN) Q1 Earnings
by Zacks Equity Research
The headline numbers for Eastman Chemical (EMN) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Eastman Chemical (EMN) Q1 Earnings Beat Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 1.06% and 0.81%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Eastman Chemical to Post Q1 Earnings: What's in Store for EMN?
by Zacks Equity Research
EMN is likely to have gained from its innovation-focused growth strategy and efforts to reduce costs and boost productivity amid weak demand in certain markets.
Gear Up for Eastman Chemical (EMN) Q1 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Eastman Chemical (EMN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Earnings Preview: LyondellBasell (LYB) Q1 Earnings Expected to Decline
by Zacks Equity Research
LyondellBasell (LYB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eastman Chemical (EMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eastman Chemical's Turbo Oil 2330 Gets Approval from U.S. Air Force
by Zacks Equity Research
U.S. Air Force approves EMN's ETO 2330 Turbo Oil, thus confirming its military-grade performance.
Eastman Chemical (EMN) Stock Jumps 12.1%: Will It Continue to Soar?
by Zacks Equity Research
Eastman Chemical (EMN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Are Options Traders Betting on a Big Move in Eastman Chemical (EMN) Stock?
by Zacks Equity Research
Investors need to pay close attention to Eastman Chemical (EMN) stock based on the movements in the options market lately.
DuPont Gains on Productivity & Innovation Amid Pricing Woes
by Zacks Equity Research
While DD faces pricing and cost headwinds, it gains on its focus on growth through innovation, acquisitions and productivity actions.
PPG Opens Waterborne Automotive Coatings Plant in Thailand
by Zacks Equity Research
The facility is expected to boost PPG's local production capacity for waterborne basecoats and primers.
BASF Joins Forestal on Advanced E-Methanol Production Using OASE
by Zacks Equity Research
BASFY is laying the groundwork for one of the first plants to produce e-methanol using its OASE technology.
Is First Trust Materials AlphaDEX ETF (FXZ) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXZ
Zacks Industry Outlook Highlights Air Products and Chemicals, DuPont de Nemours and Eastman Chemical
by Zacks Equity Research
Air Products and Chemicals, DuPont de Nemours and Eastman Chemical have been highlighted in this Industry Outlook article.
3 Diversified Chemical Stocks to Escape Demand Headwinds
by Anindya Barman
Soft demand in specific markets and the sluggishness in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. APD, DD and EMN are poised to navigate the industry challenges.
Should You Invest in the First Trust Materials AlphaDEX ETF (FXZ)?
by Zacks Equity Research
Sector ETF report for FXZ